The T1D Index is a first-of-its-kind data simulation tool that measures the human and public health impact of the T1D crisis in every country across the globe.
Eye damage in people living with type 1 diabetes (T1D) People living with T1D are 25 times more likely to develop vision loss than those living without the condition. The strict control of blood glucose levels necessary for the prevention of diabetic eye disease (retinopathy) is often difficult to achieve. Further, even if blood glucose […]
One key area of research for slowing and preventing the onset of type 1 diabetes (T1D) is understanding how to stop the immune system from attacking and destroying the cells in the pancreas that produce insulin. What is the IMPACT Trial? A new JDRF-funded study, known as the IMPACT trial, is testing if a new […]
Three Australian children are diagnosed with type 1 diabetes (T1D) every day, and of those, one-third are not diagnosed until they require emergency medical care. Screening for T1D at a population level is therefore essential for detecting a majority of the children at risk of diagnosis. In July 2022, the Type 1 Diabetes National Screening […]
JDRF has an ambitious vision — a world without type 1 diabetes (T1D). We are the biggest funder of type 1 diabetes research globally and in Australia. In order to achieve this with such a complex autoimmune disease, we must take a strategic, multi-level and collaborative approach to research. JDRF has embarked on an extensive […]
Dr Izzy Smith specialises in endocrinology and we spoke to her for some guidance on Covid-19 for people living with type 1 diabetes.
This week, new results published in the journal Microbiome showed that a six-week food supplement for people with T1D resulted in changes to bacteria in the gut and a strengthened immune system. The results are from a clinical trial funded through JDRF’s Type 1 Diabetes Clinical Research Network (T1DCRN) and Macquarie Group Foundation Future Research […]
An analysis of the impact of the Australian Government’s continuous glucose monitoring (CGM) subsidy scheme for people aged under 21 has recently been published in the journal Diabetes Care. Led by Prof Tim Jones and the Australasian Diabetes Data Network (ADDN) Study Group, the study found that those who registered for the subsidy had significant […]
Our research roundups bring you the most exciting T1D research stories from around the world – the new advances in treatment, devices and knowledge that are making the biggest impact in the fight to cure, treat and prevent T1D. Here’s what you need to know in T1D research this month: Exciting results from clinical trials […]
